Log in
Enquire now
‌

US Patent 11459335 N/O-linked Degrons and Degronimers for protein degradation

Patent 11459335 was granted and assigned to C4 Therapeutics on October, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
C4 Therapeutics
C4 Therapeutics
0
Date Filed
December 19, 2019
0
Date of Patent
October 4, 2022
0
Patent Applicant
C4 Therapeutics
C4 Therapeutics
0
Patent Application Number
16721650
0
Patent Citations
‌
US Patent 10849982 C3-carbon linked glutarimide degronimers for target protein degradation
‌
US Patent 10351568 Compositions and methods for enhancing proteasome activity
‌
US Patent 10646575 Heterocyclic degronimers for target protein degradation
‌
US Patent 10660968 Spirocyclic degronimers for target protein degradation
0
Patent Citations Received
‌
US Patent 12091397 Dihydroquinolinones for medical treatment
0
‌
US Patent 11802131 Glutarimides for medical treatment
Patent Inventor Names
Yanke Liang
0
Minsheng He
0
Martin Duplessis
0
James A. Henderson
0
Christopher G. Nasveschuk
0
Chi-Li Chen
0
Andrew J. Phillips
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11459335
0
Patent Primary Examiner
‌
Bruck Kifle
0
CPC Code
‌
C07D 487/04
0
‌
C07D 471/04
0
‌
C07D 413/12
0
‌
C07D 405/12
0
‌
A61K 31/426
0
‌
C07D 401/14
0
‌
C07D 401/12
0
‌
C07D 211/88
0
‌
C07D 207/456
0
‌
C07D 495/14
0
•••

Find more entities like US Patent 11459335 N/O-linked Degrons and Degronimers for protein degradation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.